10 Followers on Owler

iTeos

is a clinical-stage biotechnology company that researches and develops immunotherapies for the treatment of cancer... Read more
OverviewCompetitorsFundingNews & Insights

iTeos

is a clinical-stage biotechnology company that researches and develops immunotherapies for the treatment of cancer... Read more
iTeos President & CEO: Michel Detheux

President & CEO

Michel Detheux

CEO Approval Rating

90/100

2011

PublicIndependent CompanyNASDAQITOS

Pharmaceuticals & Biotechnology
PharmaceuticalsBiotechnology
28342836 NAICS listing

Annual Revenue
$35M
Employees
173
Funding
$333.1M

News

Conference Presentation
Jan 08, 2025
Marketscreener
ITeos to Present at the 43rd Annual J.P. Morgan Healthcare Conference

iTeos Competitors

1Arcus
2Corvus
3Mereo BioPharma
4Montis Biosciences
5Cristal Therapeutics
6NexImmune
7Aura
8Jounce
9Perthera
10Juno Therapeutics
Unlock 11 + competitors

Trending Companies